Detalles del proyecto
| Estado | Activo |
|---|---|
| Fecha de inicio/Fecha fin | 4/8/22 → 1/30/27 |
Financiación
- Astellas Pharma Global Development Incorporated: 244.013,00 US$
A Phase 1/2 Study of ASP1570 as Monotherapy and in Combination with Pembrolizumab in Participants with Locally Advanced or Metastatic Solid Tumors
- Villano, PhD, John (PI)
- Chauhan, Aman (Former PI)